Full Event Guide

Last Brochure Cover

5 Takeaways You Cannot Afford to Miss:

  • Navigate developing surrogate endpoints and real-world evidence with the FDA, Bayer, and Pfizer
  • Execute precision medicine approaches to targeted therapeutics with AstraZeneca, Goldfinch Bio, and University of Michigan
  • Transform your translational strategy and confidently progress novel therapeutics to the clinic with Novo Nordisk, Johnson & Johnson, and Novartis
  • Harness advances in innovative trial design with Chinook, GSK, National Kidney Foundation,
    and Boehringer Ingelheim
  • Critically assess opportunities to target rare renal diseases with Sanofi, Otsuka, and Alexion